glp 1 in development Timeline of critical milestones the and use of GLP-1 GLP-1 Reporter Cells | Incretin

[DOI] [PubMed] [Google Scholar] 5.Hasadsri L, Wang BH, Lee JV, Erdman JW, Llano DA, Barbey AK, et al

(2023) 14:1239182/BIBTEX

A study of dosages up to 15 grams per day showed no adverse effects and most importantly, the participants had improved liver health scores.* 19 Another study found that there were no gastrointestinal effects at 35 grams per day

106 Two additional clinical trials are being conducted to gather more data on adverse effects in different situations of liver injury, and a phase 2 trial investigating treatment effects for MASH with fibrosis based on histological assessment is ongoing (NCT05877547)

Shimohama S

Ingredient sourcing and product standards also appear transparent